Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
WATERTOWN, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with...
-
SupplySide Connect New Jersey gathered professionals from manufacturers, suppliers and retailers to drive the ingredient manufacturing industry forward
-
New York, USA, April 16, 2026 (GLOBE NEWSWIRE) -- Non-Small Cell Lung Cancer Clinical Trial Race Intensifies as 100+ Companies Competing in Therapeutic Segment Worldwide | DelveInsight The...
-
Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at ESCMID Global 2026
-
Company entered into an asset purchase agreement with Johnson & Johnson (J&J) to acquire all interests in botaretigene sparoparvovec (bota-vec) for the treatment of X-linked retinitis...
-
DEER PARK, Ill., April 16, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and...
-
Ms. Deardorf is an experienced biopharma leader who will lead business development and corporate and commercial strategy as Neutrolis advances NTR-1011 into autoimmune diseases following positive...
-
Delray Beach, FL, April 15, 2026 (GLOBE NEWSWIRE) -- According to recent report published by MarketsandMarkets, the global nutraceutical excipients market is projected to grow from USD 4.98 billion...
-
Totaligent (OTCID:TGNT) executed a Definitive Agreement with for the strategic acqui-hire of the Aetherium Medical platform and team.
-
New York, USA, April 14, 2026 (GLOBE NEWSWIRE) -- The Psoriasis Clinical Trial Pipeline Boom as 90+ Companies are in the Race for Better Treatments | DelveInsight The psoriasis clinical trial...